3 of the best ASX 200 shares to buy now with $5,000

Investors with money to invest might want to check out these shares that analysts rate as buys.

Do you have $5,000 ready to invest? Whether you're topping up your portfolio or getting started on your ASX journey, choosing the right shares now could make a meaningful difference over the long term.

In today's uncertain market, quality matters. That means focusing on companies with strong fundamentals, durable earnings, and the ability to grow through cycles.

With that in mind, here are three of the best ASX 200 shares to consider buying right now according to analysts — each offering something a little different, but all built for long-term success. They are as follows:

Three happy office workers cheer as they read about good financial news on a laptop.

Image source: Getty Images

CSL Ltd (ASX: CSL)

CSL is one of the Australian share market's most iconic companies — and for good reason. This biotech giant develops life-saving therapies across immunology, vaccines, and rare diseases.

The company already has a world class product portfolio, but this doesn't stop it from investing US$1 billion+ into R&D activities each year. This ensures that the company is at the forefront of the industry and has a pipeline of potentially lucrative products to drive its future growth.

Analysts are feeling very positive about the company's outlook and are forecasting double-digit earnings growth in the coming years thanks to the key CSL Behring plasma business.

Bell Potter feels that its shares are cheap based on this growth outlook. As a result, it has put a buy rating and $335.00 price target on its shares.

Pro Medicus Ltd (ASX: PME)

Another ASX 200 share to buy with the $5,000 is Pro Medicus. It is a high-margin, founder-led business that provides advanced imaging software to some of the world's leading hospitals. Its Visage platform helps radiologists analyse medical images faster and more efficiently — a critical need in modern healthcare.

Backed by long-term contracts, Pro Medicus generates strong recurring revenue, incredible operating margins, and returns on capital most companies can only dream of.

And while it trades at a premium, this is arguably justified given its quality and long term growth potential.

Goldman Sachs sees plenty of upside for investors. The broker has put a buy rating and $309.00 price target on its shares.

Woolworths Group Ltd (ASX: WOW)

Finally, Woolworths could be an ASX 200 share to buy according to analysts.

When markets get rocky, Woolworths is the kind of business investors tend to lean on. With a dominant position in Australian supermarkets, a strong loyalty program, and reliable cash flow, it offers defensive stability with modest growth.

While it may not deliver the same excitement as a tech stock, its steady dividends, strong market position and brand loyalty make it a great anchor for any portfolio.

Goldman Sachs is also bullish on this one. It has a buy rating and $36.50 price target on its shares.

Motley Fool contributor James Mickleboro has positions in CSL and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goldman Sachs Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Man looking at two roads going in different directions.
Blue Chip Shares

CSL vs Telstra: Which ASX blue chip has the better outlook?

CSL and Telstra are two ASX blue chips with very different outlooks—here’s which one I’d pick as the better buy…

Read more »

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

2 ASX blue-chip shares offering large dividend yields

These leaders offer investors significant investment income.

Read more »

Happy young woman saving money in a piggy bank.
Blue Chip Shares

This is the ASX share I'd trust with my money for the next 30 years

Three decades is an enormous investment horizon, but one business stands out to me.

Read more »

Man looking down and trying to work his laptop.
Blue Chip Shares

CBA vs Wesfarmers: Which looks best for a 50-year-old investor in 2026?

Which ASX blue chip—CBA or Wesfarmers—looks best right now for 50-year-old investors?

Read more »

Stacks of coins in ascending order with a plant on top, next to a piggy bank.
Blue Chip Shares

Droneshield vs BHP shares: Which ASX stock is better for long-term wealth?

I compare Droneshield and BHP shares to decide which looks the better bet to build long-term wealth for a 40-year-old…

Read more »

CEO of a company talking to her team.
Blue Chip Shares

CSL vs BHP shares: Should you swap after CSL's new CEO appointment?

Yesterday, CSL named Deborah Waterhouse as its next CEO. Should investors now pick CSL over BHP?

Read more »

Person holding blue chips.
Blue Chip Shares

Fortescue vs Coles shares: Which ASX blue chip wins this month?

Which delivers more long-term wealth potential: high-yielding Fortescue or steady Coles? Here’s my opinion — with all the key numbers…

Read more »

flying asx share price represented by businessman flying through the air
Blue Chip Shares

Ansell vs Ampol: Which outperforming ASX 200 stock can keep climbing in 2026?

Ampol and Ansell are both flying high, but one stands out for value, yield, and momentum in 2026—see which stock…

Read more »